AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Friday: Sources

Mar 09, 2022

New Delhi [India], March 9 : All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster...

Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials

Jan 28, 2022

New Delhi [India], January 28 : The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials...

SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose

Jan 04, 2022

New Delhi [India], January 4 : The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on...

Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster dose clinical trials, submits application

Dec 20, 2021

New Delhi [India], December 20 : As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted...

DCGI approves '5-arms intranasal hetrologous booster dose' for restricted use

Nov 25, 2022

The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is...

Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID booster intranasal vaccine

Jan 05, 2022

New Delhi [India], January 5 : The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to...